Chest
Clinical Investigationsα1-Antitrypsin Deficiency in 26-Year-Old Subjects: Lung, Liver, and Protease/Protease Inhibitor Studies
Section snippets
Study Population
All surviving 178 AAT-deficient subjects (PiZ, n = 122; PiZ−, n = 2; and PiSZ,/PiS−, n = 53) identified by the 1972-to-1974 screening were invited to participate. Clinical examination, spirometry, and routine blood tests were performed by a chest physician at the local hospital. An age-matched control group was recruited from the University Hospital in Malmö.
Questionnaire
The physician answered a questionnaire concerning diagnosis, spirometry, and liver function tests. The patient completed a modified
Clinical Examination and Lung Function
Of the 178 AAT-deficient individuals, 119 subjects (67%) underwent clinical examination at age 26 years. The patient questionnaire was answered by 134 individuals (81%). The control group of healthy volunteers included 44 PiMM individuals (21 men) with a normal AAT concentration.
Lung function test results are shown in Table 1. No significant differences in lung function were found between the Pi subgroups. A reversibility test was performed in 71 AAT-deficient and 40 PiMM individuals. An
Discussion
This study was initiated in the 1970s to determine the natural histories of liver and lung disease in AAT deficiency and the possible effects of exogenous and endogenous factors. Other important aims were to prevent smoking and to study possible compensatory changes in the protease/protease inhibitor balance.
The 26-year-old individuals with AAT deficiency have normal lung function, as defined by a normal FEV1/FEV ratio and no difference from an age-matched control group. Seven percent of those
ACKNOWLEDGMENT
The authors thank the Swedish physicians who made this study possible by reporting data to the investigators.
References (39)
- et al.
Endotoxemia and acute phase proteins in major abdominal surgery
Am J Surg
(2001) - et al.
Classification of α-2-macroglobulin-cytokine interactions based on affinity of non-covalent association in solution under apparent equilibrium conditions
J Biol Chem
(1994) - et al.
The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderphore-mediated iron acquisition
Mol Cell
(2002) American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with α-1-antitrypsin deficiency
Am J Respir Crit Care Med
(2003)- et al.
Practical genetics: α-1-antitrypsin deficiency and the serinopathies
Eur J Genet
(2004) Liver disease in α-1-antitrypsin deficiency detected by screening of 200.00 infants
N Engl J Med
(1976)- et al.
Lung function in adolescents with α-1-antitrypsin deficiency
Acta Paediatr
(1994) - et al.
Respiratory symptoms and lung function in young adults with severe α-1-antitrysin deficiency (PiZ)
Thorax
(2002) - et al.
The liver in adolescents with α-1-antitrypsin deficiency
Hepatology
(1995) Epidemiology standardization project (American Thoracic Society)
Am Rev Respir Dis
(1978)
Spirometric studies in normal subjects
Acta Med Scand
Computer-supported interpretation of protein profiles after capillary electrophoresis
Clin Chem
Adolescents with α-1-antitrypsin deficiency have high α-2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma
Pediatr Res
α-1-antitrypsin and other acute phase reactants in liver disease
Acta Med Scand
Health in Sweden
National Public Health Rep
Role of respiratory infection in onset of asthma and chronic obstructive pulmonary disease
Clin Exp Allergy
Siblings day-care attendance and the risk of asthma and wheezing during childhood
N Engl J Med
Prenatal and postnatal environmental tobacco smoke exposure and children's health
Pediatrics
Cited by (0)
This study was supported by grants from the Swedish Heart Lung Association.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).